John J. Kavanagh

Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant

David M. Gershenson, Charlotte C. Sun, Diane C. Bodurka et al. · Gynecologic Oncology · 2009 · 286 citations

Medicine, Gynecology, Oncology +12

Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum

David M. Gershenson, Charlotte C. Sun, Revathy B. Iyer et al. · Gynecologic Oncology · 2012 · 208 citations · Full text

Medicine, Oncology, Surgery +14

An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies

Marisa A. Navo, Julie Phan, Christy Vaughan et al. · Journal of Clinical Oncology · 2004 · 197 citations

Pharmacy, Oncology, Breast Oncology +11

Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer

Saroj Vadhan‐Raj, Claire F. Verschraegen, Carlos Bueso-Ramos et al. · Annals of Internal Medicine · 2000 · 195 citations

Medicine, Oncology, Pharmacology +17

Phase 1b‐2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum‐resistant or platinum‐refractory epithelial ovarian cancer

Siqing Fu, Wei Hu, Revathy B. Iyer et al. · Cancer · 2010 · 184 citations · Full text

Medicine, Oncology, Pharmacology +17